Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

AI can help design AI systems: automating architecture choices, discovering algorithms, and optimizing hardware ...

Here are seven biopharma-related trends for 2026 that have emerged from GEN interviews with experts and other industry stakeholders, and from reviews of reports and public statements.

With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect ...

Viewed this way, a definition is a decision mechanism. It distinguishes some elements of the universe from the others. Hence ...

Meta’s AI organization underwent tremendous change in 2025. After the disappointing debut of its flagship Llama 4 model, ...

The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...

Patronus AI unveiled “Generative Simulators,” adaptive “practice worlds” that replace static benchmarks with dynamic ...

Anthropic's chief scientist Jared Kaplan says humanity will soon have a big decision to make on whether to take the "ultimate ...